273.37
price up icon2.23%   5.97
after-market 시간 외 거래: 273.37
loading
전일 마감가:
$267.40
열려 있는:
$271.09
하루 거래량:
666.12K
Relative Volume:
0.74
시가총액:
$40.08B
수익:
$5.02B
순이익/손실:
$1.31B
주가수익비율:
30.68
EPS:
8.91
순현금흐름:
$1.56B
1주 성능:
+7.52%
1개월 성능:
+7.41%
6개월 성능:
+9.84%
1년 성능:
+30.47%
1일 변동 폭
Value
$270.62
$273.38
1주일 범위
Value
$253.09
$273.38
52주 변동 폭
Value
$196.43
$273.38

Resmed Inc Stock (RMD) Company Profile

Name
명칭
Resmed Inc
Name
전화
(858) 746-2400
Name
주소
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Name
직원
9,980
Name
트위터
@resmed
Name
다음 수익 날짜
2024-10-24
Name
최신 SEC 제출 서류
Name
RMD's Discussions on Twitter

RMD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Instruments & Supplies icon
RMD
Resmed Inc
273.37 39.21B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
501.95 183.15B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
182.58 51.96B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
92.22 43.85B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
227.31 15.73B 2.90B 467.20M 306.90M 6.37

Resmed Inc Stock (RMD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-07-15 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2025-03-19 개시 Morgan Stanley Overweight
2025-01-16 개시 Goldman Buy
2025-01-10 개시 Piper Sandler Neutral
2024-12-13 개시 Stifel Hold
2024-09-24 개시 Robert W. Baird Outperform
2024-09-18 다운그레이드 Wolfe Research Peer Perform → Underperform
2024-09-04 다운그레이드 Needham Buy → Hold
2024-06-25 다운그레이드 Oppenheimer Outperform → Perform
2024-06-24 다운그레이드 Citigroup Buy → Neutral
2024-02-06 재개 KeyBanc Capital Markets Overweight
2023-10-27 업그레이드 Morgan Stanley Equal-Weight → Overweight
2023-10-12 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-10-09 업그레이드 JP Morgan Neutral → Overweight
2023-09-29 다운그레이드 Wolfe Research Outperform → Peer Perform
2023-09-06 업그레이드 Needham Hold → Buy
2023-09-05 다운그레이드 UBS Buy → Neutral
2023-08-01 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2023-05-23 개시 UBS Buy
2023-04-14 개시 Mizuho Buy
2023-01-17 업그레이드 JP Morgan Neutral → Overweight
2022-10-28 다운그레이드 Citigroup Buy → Neutral
2022-10-20 업그레이드 BofA Securities Neutral → Buy
2022-10-12 개시 Jefferies Hold
2022-09-08 업그레이드 Citigroup Neutral → Buy
2022-08-15 다운그레이드 CLSA Buy → Outperform
2022-08-12 다운그레이드 Citigroup Buy → Neutral
2022-08-12 다운그레이드 JP Morgan Overweight → Neutral
2022-08-12 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2022-06-06 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2022-04-06 개시 Wolfe Research Outperform
2022-01-31 업그레이드 Citigroup Neutral → Buy
2022-01-31 업그레이드 Goldman Neutral → Buy
2022-01-28 업그레이드 RBC Capital Mkts Underperform → Sector Perform
2022-01-24 업그레이드 BofA Securities Underperform → Neutral
2022-01-24 업그레이드 JP Morgan Neutral → Overweight
2022-01-13 업그레이드 CLSA Outperform → Buy
2022-01-13 업그레이드 Robert W. Baird Neutral → Outperform
2021-12-21 업그레이드 KeyBanc Capital Markets Sector Weight → Overweight
2021-12-06 업그레이드 Macquarie Neutral → Outperform
2021-10-22 업그레이드 CLSA Underperform → Outperform
2021-08-02 다운그레이드 CLSA Outperform → Sell
2021-08-02 다운그레이드 Needham Buy → Hold
2021-07-28 업그레이드 Jefferies Underperform → Hold
2021-07-26 다운그레이드 JP Morgan Overweight → Neutral
2021-07-14 개시 RBC Capital Mkts Underperform
2021-06-28 다운그레이드 Citigroup Buy → Neutral
2021-06-22 업그레이드 Macquarie Neutral → Outperform
2021-06-22 개시 Robert W. Baird Neutral
2021-06-21 재확인 Needham Buy
2021-06-16 다운그레이드 BofA Securities Neutral → Underperform
2021-06-09 업그레이드 CLSA Sell → Outperform
2021-05-21 업그레이드 JP Morgan Neutral → Overweight
2021-05-11 업그레이드 Citigroup Neutral → Buy
2021-04-30 다운그레이드 Citigroup Buy → Neutral
2021-03-16 업그레이드 Needham Hold → Buy
2020-11-02 업그레이드 UBS Neutral → Buy
2020-10-30 업그레이드 JP Morgan Underweight → Neutral
2020-10-27 업그레이드 BofA Securities Underperform → Neutral
2020-08-07 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-06-17 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-05-01 다운그레이드 JP Morgan Neutral → Underweight
2020-05-01 업그레이드 Oppenheimer Perform → Outperform
2020-02-18 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-02-03 개시 CLSA Underperform
2020-01-31 다운그레이드 UBS Buy → Neutral
2020-01-10 개시 Oppenheimer Perform
2019-11-22 개시 KeyBanc Capital Markets Sector Weight
2019-07-29 업그레이드 UBS Neutral → Buy
2019-07-16 다운그레이드 UBS Buy → Neutral
2019-05-06 업그레이드 UBS Neutral → Buy
2019-04-18 업그레이드 JP Morgan Underweight → Neutral
2019-01-25 다운그레이드 Goldman Buy → Neutral
2019-01-25 다운그레이드 JP Morgan Neutral → Underweight
2018-10-26 업그레이드 Credit Suisse Neutral → Outperform
2018-07-02 개시 Goldman Buy
모두보기

Resmed Inc 주식(RMD)의 최신 뉴스

pulisher
04:01 AM

MIN and Resmed CDI: 2 ASX shares to dig into - Rask Media

04:01 AM
pulisher
09:15 AM

ResMed Inc. (RMD) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance

09:15 AM
pulisher
03:04 AM

What drives ResMed Inc. stock priceFree Investment Timing Strategies - jammulinksnews.com

03:04 AM
pulisher
01:38 AM

ResMed Inc. Stock Analysis and ForecastFree Investment Portfolio Suggestions - Autocar Professional

01:38 AM
pulisher
Jul 22, 2025

What analysts say about ResMed Inc. stockSkyrocketing investment returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is ResMed Inc. a good long term investmentMarket-beating returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

ResMed stock hits 52-week high at 263.62 USD By Investing.com - Investing.com South Africa

Jul 22, 2025
pulisher
Jul 21, 2025

Sleep Apnea Devices Market is expected to generate a revenue of USD 14.59 Billion by 2031, Globally, at 10.42 % CAGR: Verified Market Research® - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 19, 2025

Published on: 2025-07-19 18:08:41 - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What makes ResMed Inc. stock attractive to long term investorsTrend Based Entry Alerts - beatles.ru

Jul 19, 2025
pulisher
Jul 17, 2025

This ResMed Insider Reduced Their Stake By 72% - simplywall.st

Jul 17, 2025
pulisher
Jul 17, 2025

This Pick Withstood the GLP-1 Challenge. Stick With the Stock. - Barron's

Jul 17, 2025
pulisher
Jul 16, 2025

Analyst Expectations For ResMed's Future - Nasdaq

Jul 16, 2025
pulisher
Jul 16, 2025

ResMed (RMD) Price Target Increased to $270 by Mizuho Analyst | - GuruFocus

Jul 16, 2025
pulisher
Jul 16, 2025

Brokers Set Expectations for ResMed's Q1 Earnings (NYSE:RMD) - MarketBeat

Jul 16, 2025
pulisher
Jul 15, 2025

RBC Upgrades ResMed to Outperform From Sector Perform, Adjusts Price Target to $294 From $255 - MarketScreener

Jul 15, 2025
pulisher
Jul 14, 2025

ResMed's Trading Volume Surges 78.7% to 2.35 Billion, Stock Price Drops 0.11% Placing 406th in Market Rankings - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

ResMed (NYSE:RMD) Seems To Use Debt Rather Sparingly - 富途牛牛

Jul 14, 2025
pulisher
Jul 09, 2025

ResMed CEO Executes Stock Transactions Under Rule 10b5-1 Plan - TipRanks

Jul 09, 2025
pulisher
Jul 09, 2025

Resmed CEO Farrell sells $2.06 million in stock By Investing.com - Investing.com Canada

Jul 09, 2025
pulisher
Jul 09, 2025

Resmed Insider Sold Shares Worth $2,056,076, According to a Recent SEC Filing - MarketScreener

Jul 09, 2025
pulisher
Jul 07, 2025

ResMed Inc. Officer Plans Sale of Common Stock Under Rule 144 - TipRanks

Jul 07, 2025
pulisher
Jul 05, 2025

With 75% institutional ownership, ResMed Inc. (NYSE:RMD) is a favorite amongst the big guns - simplywall.st

Jul 05, 2025
pulisher
Jul 03, 2025

ResMed CFO Reports Changes in Stock Ownership - TipRanks

Jul 03, 2025
pulisher
Jul 03, 2025

ResMed to Release Q4 2025 Financial Results on July 31, 2025, via Webcast - AInvest

Jul 03, 2025
pulisher
Jul 02, 2025

ResMed Executives Sell Shares Under Pre-arranged Trading Plans - TradingView

Jul 02, 2025
pulisher
Jul 02, 2025

ResMed Director Announces Further Share Sale - TipRanks

Jul 02, 2025
pulisher
Jul 01, 2025

ResMed Chief Legal Officer Sells Shares - MarketScreener

Jul 01, 2025
pulisher
Jul 01, 2025

Resmed Inc Officer Files Notice for Stock Sale Under Rule 144 - TipRanks

Jul 01, 2025
pulisher
Jul 01, 2025

Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025 | RMD Stock News - GuruFocus

Jul 01, 2025
pulisher
Jul 01, 2025

Resmed Announces Fourth Quarter Fiscal Year 2025 Financial Results Release and Webcast Details - Quiver Quantitative

Jul 01, 2025
pulisher
Jul 01, 2025

ResMed (NYSE:RMD) Shows Growth in ROCE and Business Efficiency NYSE Composite - Kalkine Media

Jul 01, 2025
pulisher
Jul 01, 2025

ResMed (NYSE:RMD) Could Become A Multi-Bagger - Yahoo Finance

Jul 01, 2025
pulisher
Jun 26, 2025

Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed - Yahoo Finance

Jun 26, 2025
pulisher
Jun 25, 2025

All You Need to Know About ResMed (RMD) Rating Upgrade to Buy - Yahoo Finance

Jun 25, 2025
pulisher
Jun 19, 2025

Is the ResMed share price still cheap? What the numbers say - The Motley Fool Australia

Jun 19, 2025
pulisher
Jun 18, 2025

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance

Jun 18, 2025
pulisher
Jun 17, 2025

Bi Level Automatic Ventilator Market Is Booming Worldwide 2025-2032 | ResMed Inc., Philips Healthcare, Medtronic Plc - openPR.com

Jun 17, 2025
pulisher
Jun 16, 2025

ResMed Stock: Is RMD Outperforming the Healthcare Sector? - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

ResMed Inc. (RMD) Investor Outlook: Analyzing Growth Potential Amidst a 6% Upside - DirectorsTalk Interviews

Jun 16, 2025
pulisher
Jun 16, 2025

ResMed Stock: Is RMD Outperforming The Healthcare Sector? - Barchart.com

Jun 16, 2025
pulisher
Jun 10, 2025

Resmed CEO Michael Farrell sells shares worth $2.01 million By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

ResMed: A Mixed Bag for Investors Amid Rising Competition - The Globe and Mail

Jun 10, 2025
pulisher
Jun 10, 2025

Resmed CEO Michael Farrell sells shares worth $2.01 million - Investing.com

Jun 10, 2025
pulisher
Jun 09, 2025

ResMed CEO Sells Shares Worth $2 Million - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

ResMed Inc Reports Change in Beneficial Ownership - TipRanks

Jun 09, 2025
pulisher
Jun 09, 2025

ResMed: A Sleeping Giant Hiding In Plain Sight (NYSE:RMD) - Seeking Alpha

Jun 09, 2025
pulisher
Jun 08, 2025

Up more than 75% since October 2023 — are ResMed shares a buy, hold or sell? - MSN

Jun 08, 2025

Resmed Inc (RMD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Resmed Inc 주식 (RMD) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Farrell Michael J.
Chief Executive Officer
Jul 07 '25
Sale
256.72
8,009
2,056,076
455,503
medical_instruments_supplies ALC
$92.22
price up icon 4.02%
medical_instruments_supplies BDX
$182.58
price up icon 0.72%
medical_instruments_supplies WST
$227.31
price up icon 3.84%
$204.13
price up icon 5.19%
$65.95
price up icon 0.89%
자본화:     |  볼륨(24시간):